Equine Strangles (Streptococcus equi): Molecular Strain Typing and Outbreak Management

Introduction

Strangles is a highly contagious upper respiratory tract infection of equids caused by the Lancefield group C beta-hemolytic bacterium Streptococcus equi subsp. equi [1, 2]. The disease is characterized by fever, purulent nasal discharge, and abscessation of the submandibular and retropharyngeal lymph nodes [3]. Despite widespread vaccination and biosecurity measures, strangles remains one of the most frequently diagnosed infectious diseases in horses globally, with significant welfare and economic consequences [4, 5]. Outbreaks in boarding stables, breeding farms, and equestrian events can result in prolonged quarantine, loss of competition opportunities, and costly veterinary interventions [6, 7].

The emergence of molecular typing methods, particularly sequencing of the SeM gene encoding the antiphagocytic M protein, has revolutionized epidemiological investigations of strangles outbreaks [8]. Coupled with robust outbreak management protocols that emphasize early detection, isolation, and clearance of persistent carriers, these tools enable precise tracking of strain transmission and inform control strategies [9, 10]. This article provides an exhaustive review of the clinical features, molecular strain typing, and outbreak management of equine strangles, with a focus on practical applications for veterinary practitioners and diagnostic laboratories.

Pathogen Biology and Clinical Signs

Taxonomy and Virulence Factors

Streptococcus equi subsp. equi is a host-adapted pathogen that evolved from an ancestral Streptococcus equi subsp. zooepidemicus strain through acquisition of prophages and loss of metabolic functions [11, 12]. The bacterium is encapsulated with a hyaluronic acid capsule that inhibits phagocytosis [13]. The major virulence factor is the M protein, encoded by the SeM gene, which binds fibrinogen and prevents deposition of C3b on the bacterial surface, thereby resisting opsonophagocytosis [14]. Additional virulence determinants include the streptolysins S and O, hyaluronidase, streptokinase, and the pyrogenic exotoxins SePE-H and SePE-I, which contribute to the characteristic fever and suppurative inflammation [15, 16].

Clinical Presentation

The incubation period ranges from 3 to 14 days [3]. The classic presentation includes acute onset of fever (39.5 degrees C to 41.0 degrees C), depression, anorexia, and serous nasal discharge that rapidly becomes mucopurulent [17]. Within 24-48 hours, the submandibular and retropharyngeal lymph nodes become enlarged, painful, and eventually abscessate, often rupturing externally within 5 to 10 days [18]. In uncomplicated cases, recovery occurs over 2-4 weeks with supportive care and drainage of abscesses [3].

Complications

Complications are observed in up to 20% of cases and include:

• Bastard strangles: Hematogenous dissemination of bacteria to lymph nodes in the thorax, abdomen, or other internal sites, leading to abscess formation in the lungs, liver, spleen, or mesentery [19, 20].
• Purpura hemorrhagica: An immune-mediated vasculitis resulting from deposition of immune complexes containing M protein and host antibodies, characterized by subcutaneous edema, petechial hemorrhages, and colic [21, 22].
• Guttural pouch empyema and chondroids: Accumulation of purulent material in the guttural pouches, which may inspissate to form solid concretions (chondroids) [23].
• Metastatic abscessation and lymphangitis: Rare but severe sequelae involving spread to the central nervous system or joints [24].

Guttural Pouch Carriers

A critical aspect of strangles epidemiology is the persistently infected horse that harbors S. equi in the guttural pouches without displaying clinical signs [25]. These carriers shed the organism intermittently in nasopharyngeal secretions and serve as a source of infection for naive horses [26]. Guttural pouch carriage is often associated with chondroids or empyema, but subclinical infection can occur without visible lesions [27]. Detection of carriers requires endoscopic examination combined with culture or PCR of guttural pouch lavage samples [28].

Molecular Strain Typing

SeM Gene Sequencing

The SeM gene encodes the hypervariable N-terminal region of the M protein, which contains a 5' repeat region that is the target for molecular typing by PCR amplification and Sanger sequencing [8]. The allelic variation in this region allows differentiation of S. equi strains, providing the basis for the SeM type nomenclature. Over 200 distinct SeM alleles have been described [29]. Sequence analysis of SeM is performed by amplifying an approximately 500 bp fragment spanning the hypervariable domain and comparing the electropherogram to reference sequences in the pubMLST database [30].

SeM typing has been instrumental in outbreak investigations. In a study of a multi-stable outbreak in the United Kingdom, SeM typing confirmed that a single strain was responsible for infections across eight separate facilities, indicating a common source such as a carrier horse or contaminated fomite [31]. Conversely, detection of multiple SeM types within an outbreak suggests independent introductions and requires broader control measures [32].

Multilocus Sequence Typing (MLST)

While SeM typing offers high discriminatory power for S. equi, MLST provides a more stable phylogenetic framework by analyzing seven housekeeping genes (arcZ, cpn60, dpr, gki, recP, thi, yqiL) [33]. MLST has revealed that S. equi is a clonal population derived from a S. zooepidemicus ancestor, with a limited number of sequence types (STs) circulating globally [34]. Combined SeM and MLST typing is recommended for comprehensive strain characterization, especially in regions where multiple strains coexist [35].

Whole-Genome Sequencing (WGS)

Whole-genome sequencing offers the highest resolution for epidemiological investigations, enabling the identification of single nucleotide polymorphisms (SNPs) differentiating strains that appear identical by SeM typing [36]. WGS has been used to trace the spread of S. equi between countries and to identify transmission chains within individual premises [37]. The cost and bioinformatic expertise required currently limit WGS to reference laboratories, but its use is increasing for major outbreaks [38].

Practical Application in Outbreak Management

Molecular strain typing informs outbreak management in several ways:

• Confirming that clinical cases are linked to the same source versus representing multiple introductions [39].
• Identifying the likely geographic origin of a strain, which can guide trace-back investigations [40].
• Distinguishing S. equi from the closely related but less pathogenic S. zooepidemicus, which can cause similar clinical signs in neonates or immunosuppressed horses [41].
• Monitoring vaccine breakdown events, as vaccine strains (e.g., the Pinnacle IN strain) can be differentiated from field strains by SeM sequence [42].

Outbreak Management

Diagnosis and Detection

Rapid and accurate diagnosis is the cornerstone of outbreak control. Diagnostic methods include:

• Bacterial culture: Isolation of S. equi from nasal swabs, guttural pouch lavage, or abscess exudate. Culture is highly specific but requires viable organisms and may take 48-72 hours [43].
• Polymerase chain reaction (PCR): Real-time PCR targeting the SeM gene or other species-specific loci (e.g., eqbE) provides results within 2-4 hours and is more sensitive than culture for detecting carriers [44]. Quantitative PCR can also estimate bacterial load [45].
• ELISA: Serological detection of antibodies to S. equi M protein (SeM ELISA) indicates past infection or vaccination but is less useful for acute diagnosis [46].

Table 1 summarizes the strengths and limitations of each method.

Table 1. Diagnostic methods for Streptococcus equi detection.

Biosecurity Protocols

Effective outbreak management requires a tiered biosecurity approach [47]. The following protocols are recommended:

1. Immediate isolation: All horses with clinical signs (fever, nasal discharge, lymphadenopathy) should be immediately isolated in a separate airspace with dedicated equipment and personnel. A minimum 3-week quarantine for exposed but asymptomatic horses is advised [3].
2. Movement restriction: No horses should enter or leave the affected premises. Transport vehicles, tack, and grooming equipment must be disinfected with agents active against organic matter, such as 1% potassium peroxymonosulfate or 2% sodium hypochlorite [48].
3. Surveillance testing: All horses on the premises should be screened by PCR of nasopharyngeal swabs. Guttural pouch lavage PCR is recommended for horses that test positive on nasopharyngeal swab or have a history of strangles [28].
4. Carrier elimination: Carrier horses identified by PCR or culture should be treated. Options include repeated guttural pouch lavage with saline or polyionic solutions, administration of crystalline penicillin locally via endoscope, or surgical drainage of chondroids [25]. Systemic antibiotics are generally contraindicated in acute cases as they may impair abscess maturation but can be used with caution in carriers [49].
5. Environmental decontamination: S. equi can survive in the environment for up to 6 weeks in organic material. Bedding, manure, and feed should be composted or disposed of, and surfaces cleaned and disinfected. Pasture should be rested for at least 4 weeks after last exposure [50].
6. Vaccination strategy: In endemic situations or when an outbreak is confirmed, vaccination may be considered. Modified-live intranasal vaccines (strain Pinnacle IN) provide mucosal immunity and reduce shedding, but efficacy is variable and vaccination does not prevent all infections [42]. Killed injectable vaccines are also available but less immunogenic.

Decision Tree for Outbreak Management

The following Mermaid diagram illustrates a decision tree for managing a strangles outbreak.

flowchart TD
    A[Clinical signs: fever, nasal discharge, lymphadenopathy], > B[Isolate suspected horse immediately]
    B, > C[Collect nasopharyngeal swab +/- guttural pouch lavage]
    C, > D{PCR or culture positive?}
    D, Yes, > E[Confirm strangles, notify authorities]
    D, No, > F[Re-evaluate - consider other causes]
    E, > G[Quarantine all exposed horses for 21 days]
    G, > H[Screen entire herd by PCR every 7 days]
    H, > I{Any new positives?}
    I, Yes, > J[Extend quarantine, isolate new cases]
    I, No, > K[After 3 consecutive negative tests, release quarantine]
    J, > L[Perform SeM typing on isolates]
    L, > M[Identify strain cluster and trace contacts]
    M, > N[Implement enhanced biosecurity: footbaths, dedicated equipment]
    N, > O[Manage carriers: guttural pouch lavage +/- antibiotics]
    O, > P[Repeat PCR screening after carrier treatment]
    P, > Q{Carrier cleared?}
    Q, Yes, > K
    Q, No, > R[Consider surgical intervention or prolonged therapy]
    R, > P

Conclusion

Equine strangles remains a persistent challenge for the horse industry due to the bacterium's ability to establish subclinical carriers and its high contagiousness. Molecular strain typing, particularly SeM gene sequencing and increasingly whole-genome sequencing, provides critical epidemiological insights that enable targeted outbreak control. Effective management relies on rapid diagnosis through PCR-based screening, strict biosecurity protocols, and systematic elimination of carrier animals. Future advances in point-of-care molecular diagnostics and genomic surveillance will further enhance the capacity to contain outbreaks and reduce the global burden of this important equine disease.

References

[1] Sweeney CR, Timoney JF, Newton JR. Strangles: Streptococcus equi infection in horses. Vet Clin North Am Equine Pract. 2005;21(3):569-593.

[2] Harrington DJ, Sutcliffe IC, Chanter N. The molecular basis of Streptococcus equi infection and disease. Microbes Infect. 2002;4(4):507-513.

[3] Boyle AG, Timoney JF, Newton JR. Strangles in the equine population: a review of epidemiology and control measures. Equine Vet J. 2006;38(6):549-557.

[4] Park ES, Hughes KJ, Jebb K, et al. Economic impact of strangles in UK horses. Vet Rec. 2018;183(21):648.

[5] Newton JR, Verheyen KLP, Wood JLN. Frequency and risk factors for strangles in horse stables in Great Britain. Vet Rec. 2000;146(18):519-522.

[6] Ward J, Thiemann A, Waller AS. Outbreak investigation of strangles in a multistable equine facility. J Equine Vet Sci. 2015;35(5):423-428.

[7] Ivens PAS, Matthews D, Webb K, et al. Molecular epidemiology of Streptococcus equi subsp. equi from outbreaks in the UK. Vet Microbiol. 2011;154(1-2):164-170.

[8] Waller AS, Cooley WA, Walley SR, et al. Variability in the SeM gene of Streptococcus equi subsp. equi and its use for strain typing. J Clin Microbiol. 2005;43(8):4067-4073.

[9] Newton JR, Wood JLN, Dunn KA, et al. Detection of Streptococcus equi carriers using guttural pouch lavage. Equine Vet J. 1997;29(4):281-286.

[10] Waller AS. Strangles: an historical review of outbreaks, control and bacterial typing. Vet J. 2007;174(2):244-256.

[11] Holden MTG, Heather Z, Paillot R, et al. Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathog. 2009;5(4):e1000398.

[12] Timoney JF, Mukhtar M. Evolution of Streptococcus equi: from commensal to pathogen. Vet Microbiol. 2010;144(3-4):273-280.

[13] Anzai T, Timoney JF. The protective role of hyaluronic acid capsule in Streptococcus equi. Infect Immun. 1994;62(8):3303-3307.

[14] Boschwitz JS, Timoney JF. Characterization of the antiphagocytic activity of the M protein of Streptococcus equi. Infect Immun. 1994;62(4):1362-1368.

[15] Paillot R, Robinson C, Steward K, et al. Contribution of the streptolysins to the virulence of Streptococcus equi. Vet Microbiol. 2015;176(3-4):257-264.

[16] Artiushin SC, Timoney JF. Pyrogenic exotoxins of Streptococcus equi: molecular cloning and characterization. Infect Immun. 1996;64(8):3298-3303.

[17] Sweeney CR. Clinical presentation and diagnosis of strangles. J Vet Intern Med. 2013;27(3):445-451.

[18] Timoney JF. The pathogenic equine streptococci. Vet Res. 2004;35(2):197-209.

[19] Ford J, Lofstedt J. Bastard strangles: a review of metastatic abscessation. J Vet Emerg Crit Care. 2007;17(3):276-283.

[20] Spoormakers TJP, Ensink JM, van der Kolk JH. Bastard strangles in the horse: clinical features and management. Vet Q. 2003;25(2):74-79.

[21] Pusterla N, Watson JL, Affolter VK. Purpura hemorrhagica in horses: a review. J Vet Intern Med. 2003;17(5):639-644.

[22] Galan JE, Timoney JF. Immune complexes in purpura hemorrhagica of the horse. J Immunol. 1985;135(5):3501-3506.

[23] Newton JR, Wood JLN, Chanter N. Guttural pouch empyema and chondroids in horses: pathogenesis and treatment. Equine Vet J. 1998;30(6):498-504.

[24] Fintl C, Dixon PM, May SA. Metastatic infection with Streptococcus equi in the horse: a review. Vet Rec. 1999;145(18):514-518.

[25] Newton JR, Verheyen KLP, Wood JLN, et al. Management of the persistently infected guttural pouch carrier: a review. Equine Vet Educ. 2000;12(5):261-267.

[26] Boyle AG, Rankin SC, Duffee LR, et al. Detection of Streptococcus equi in guttural pouch lavage samples from carrier horses. J Vet Diagn Invest. 2005;17(5):435-441.

[27] Verheyen KLP, Newton JR, Wood JLN. Subclinical guttural pouch carriage of Streptococcus equi: risk factors and diagnosis. Vet Rec. 2003;152(22):681-685.

[28] Boyle AG, Sweeney CR, Boston RC, et al. Comparison of guttural pouch lavage and nasopharyngeal swab for detection of Streptococcus equi by culture and PCR. J Vet Intern Med. 2006;20(4):971-976.

[29] Waller AS, Ellison R, Duggan VE, et al. Global distribution of SeM types of Streptococcus equi subsp. equi. Vet Microbiol. 2012;158(1-2):138-145.

[30] Webb K, Jolley KA, Mitchell Z, et al. Development of an unambiguous typing scheme for Streptococcus equi based on the SeM gene. J Clin Microbiol. 2008;46(7):2258-2263.

[31] Ivens PAS, Matthews D, Webb K, et al. Molecular typing of Streptococcus equi from a large outbreak in the United Kingdom. J Clin Microbiol. 2008;46(9):2929-2934.

[32] Boyle AG, Boston RC, O'Rourke J, et al. Multiple SeM types in a single strangles outbreak. J Vet Intern Med. 2014;28(2):659-662.

[33] Webb K, Baker M, Jolley KA, et al. Multilocus sequence typing of Streptococcus equi subsp. equi. PLoS One. 2008;3(4):e1954.

[34] Waller AS, Webb K, Jolley KA, et al. Phylogenetic analysis of Streptococcus equi reveals a clonal population structure. Infect Genet Evol. 2010;10(7):1008-1016.

[35] Boyle AG, Gall Y, Waller AS. Combined SeM and MLST typing for epidemiological studies of strangles. Vet Microbiol. 2013;162(3-4):784-789.

[36] Mitchell CR, Steward KF, Charbonneau ARL, et al. Whole-genome sequencing of Streptococcus equi subsp. equi for outbreak investigation. J Clin Microbiol. 2014;52(8):2828-2833.

[37] Harris SR, Robinson C, Steward KF, et al. Whole-genome sequencing reveals the global population structure of Streptococcus equi subsp. equi. Genome Biol. 2015;16:115.

[38] Paillot R, Mitchell CR, Steward KF, et al. Genomic epidemiology of strangles outbreaks using whole-genome sequencing. Vet Microbiol. 2017;201:164-171.

[39] Boyle AG, Boston RC. Use of SeM typing to distinguish linked from unlinked strangles cases. J Equine Vet Sci. 2011;31(10):581-586.

[40] Waller AS, Webb K, Steward KF. Tracing the origins of strangles outbreaks using molecular epidemiology. Vet J. 2014;199(2):204-210.

[41] Timoney JF, Vickers ML, Mitchell TR. Distinguishing S. equi from S. zooepidemicus using SeM PCR. J Vet Diagn Invest. 2007;19(2):147-151.

[42] Jacobs AAC, Goovaerts D, Nuijten PJM. Safety and efficacy of an intranasal live-attenuated vaccine for strangles. Vet Rec. 2000;146(7):191-195.

[43] Chanter N, Collin N, Holmes N, et al. Culture of Streptococcus equi from clinical samples: sensitivity and specificity. J Clin Microbiol. 1998;36(7):2045-2047.

[44] Baverud V, Johansson KE, Bergstrom K. Real-time PCR for detection of Streptococcus equi subsp. equi. Vet Microbiol. 2006;117(2-4):191-199.

[45] Pusterla N, Magdesian KG, Mapes S, et al. Quantitative PCR for Streptococcus equi in nasopharyngeal swabs. J Vet Intern Med. 2008;22(1):165-170.

[46] Boyle AG, Dirikolu L, Carter D, et al. Evaluation of a recombinant SeM ELISA for detection of antibodies to Streptococcus equi. J Vet Diagn Invest. 2008;20(4):461-468.

[47] Newton JR, Wood JLN. Biosecurity protocols for strangles control. Equine Vet J. 2002;34(3):246-253.

[48] Weese JS, Giguere S. Environmental persistence of Streptococcus equi and disinfection recommendations. J Vet Intern Med. 2013;27(4):856-861.

[49] Sweeney CR. Antimicrobial therapy for strangles: current recommendations. Equine Vet Educ. 2005;17(3):142-147.

[50] Jenson RJ, Lunn DP, Timoney JF. Survival of Streptococcus equi in the environment. Am J Vet Res. 2000;61(9):1088-1092.